Lyka Labs Limited
NSE:LYKALABS.NS
146.97 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,111.946 | 930.728 | 1,835.859 | 671.071 | 554.076 | 642.378 | 563.597 | 1,165.824 | 1,275.665 | 1,662.659 | 1,188.562 | 1,271.208 | 0 | 1,391.232 | 1,635.571 |
Cost of Revenue
| 844.189 | 375.545 | 533.024 | 381.84 | 358.67 | 393.163 | 295.36 | 538.477 | 970.915 | 907.265 | 635.334 | 669.05 | 0 | 881.97 | 1,193.823 |
Gross Profit
| 267.757 | 555.183 | 1,302.835 | 289.231 | 195.406 | 249.215 | 268.237 | 627.347 | 304.75 | 755.394 | 553.228 | 602.158 | 0 | 509.261 | 441.748 |
Gross Profit Ratio
| 0.241 | 0.597 | 0.71 | 0.431 | 0.353 | 0.388 | 0.476 | 0.538 | 0.239 | 0.454 | 0.465 | 0.474 | 0 | 0.366 | 0.27 |
Reseach & Development Expenses
| 13.9 | 14.292 | 0 | 0 | 0 | 0 | 0 | 4.792 | 0 | 0 | 24.364 | 115.945 | 0 | 0 | 0 |
General & Administrative Expenses
| 227.531 | 28.76 | 32.002 | 22.496 | 29.343 | 24.858 | 24.439 | 23.298 | 193.122 | 174.405 | 16.763 | 22.071 | 0 | 35.384 | 50.151 |
Selling & Marketing Expenses
| 11.096 | 22.823 | 27.682 | 17.4 | 19.228 | 51.745 | 2.318 | 58.243 | 19.576 | 42.111 | 110.292 | 88.48 | 0 | 106.569 | 67.889 |
SG&A
| 238.627 | 51.583 | 59.684 | 39.896 | 48.571 | 76.603 | 26.757 | 81.541 | 212.698 | 216.516 | 292.047 | 277.033 | 0 | 141.953 | 118.041 |
Other Expenses
| 14.547 | 479.716 | 412.252 | 135.737 | 310.911 | 15.805 | 15.727 | 401.537 | -8.702 | 575.545 | 533.254 | 0.112 | 0 | 48.037 | 78.896 |
Operating Expenses
| 238.627 | 531.299 | 471.936 | 175.633 | 359.482 | 343.203 | 416.437 | 483.078 | 221.4 | 575.545 | 533.254 | 516.17 | 0 | 189.99 | 196.936 |
Operating Income
| 29.13 | 57.894 | 851.668 | 126.176 | -138.285 | -89.561 | -152.62 | 74.358 | 83.35 | 167.071 | -112.474 | 6.271 | 0 | 227.087 | 164.976 |
Operating Income Ratio
| 0.026 | 0.062 | 0.464 | 0.188 | -0.25 | -0.139 | -0.271 | 0.064 | 0.065 | 0.1 | -0.095 | 0.005 | 0 | 0.163 | 0.101 |
Total Other Income Expenses Net
| -38.467 | -189.605 | -259.198 | -267.617 | -480.484 | -64.686 | -47.827 | -141.575 | -44.314 | -203.647 | 71.916 | -13.348 | 0 | -186.576 | -189.345 |
Income Before Tax
| -9.337 | -131.711 | 592.47 | -141.441 | -618.769 | -154.247 | -200.447 | -67.218 | 39.036 | -36.576 | -40.558 | -7.077 | 0 | 40.512 | -24.369 |
Income Before Tax Ratio
| -0.008 | -0.142 | 0.323 | -0.211 | -1.117 | -0.24 | -0.356 | -0.058 | 0.031 | -0.022 | -0.034 | -0.006 | 0 | 0.029 | -0.015 |
Income Tax Expense
| 16.867 | -0.187 | 208.037 | -40.534 | 7.434 | -90.728 | -10.398 | -10.305 | -1.863 | 10.64 | 12.458 | 13.348 | 0 | 0.022 | 1.323 |
Net Income
| -24.892 | -131.524 | 389.998 | -100.907 | -626.203 | -55.503 | -172.748 | -46.757 | 36.869 | -49.493 | -65.897 | -7.077 | 0 | 24.109 | -48.62 |
Net Income Ratio
| -0.022 | -0.141 | 0.212 | -0.15 | -1.13 | -0.086 | -0.307 | -0.04 | 0.029 | -0.03 | -0.055 | -0.006 | 0 | 0.017 | -0.03 |
EPS
| -0.75 | -4.57 | 13.59 | -3.52 | -21.98 | -1.97 | -6.69 | -2.12 | 1.69 | -2.29 | -3.06 | -0.33 | 0 | 1.07 | -2.86 |
EPS Diluted
| -0.75 | -4.57 | 13.59 | -3.52 | -21.98 | -1.95 | -6.69 | -2.12 | 1.65 | -2.29 | -3.05 | -0.33 | 0 | 1.07 | -2.86 |
EBITDA
| 157.148 | 199.367 | 1,025.162 | 209.414 | -58.19 | -16.424 | -39.804 | 164.527 | 176.596 | 167.706 | -24.494 | 123.229 | 0 | 283.943 | 212.336 |
EBITDA Ratio
| 0.141 | 0.214 | 0.558 | 0.312 | -0.105 | -0.026 | -0.071 | 0.141 | 0.138 | 0.101 | -0.021 | 0.097 | 0 | 0.204 | 0.13 |